These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 29105550)

  • 1. Adherence to guidelines in patients with chronic heart failure in primary health care.
    Giezeman M; Arne M; Theander K
    Scand J Prim Health Care; 2017 Dec; 35(4):336-343. PubMed ID: 29105550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
    Mejhert M; Kahan T
    Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
    Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
    Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary Drug Treatment of Chronic Heart Failure With Reduced Ejection Fraction: The CHECK-HF Registry.
    Brunner-La Rocca HP; Linssen GC; Smeele FJ; van Drimmelen AA; Schaafsma HJ; Westendorp PH; Rademaker PC; van de Kamp HJ; Hoes AW; Brugts JJ;
    JACC Heart Fail; 2019 Jan; 7(1):13-21. PubMed ID: 30606482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What primary care physicians know about diagnosis and treatment of chronic heart failure.
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A
    Kardiol Pol; 2005 Mar; 62(3):218-28. PubMed ID: 15830016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems: Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure.
    Maggioni AP; Van Gool K; Biondi N; Urso R; Klazinga N; Ferrari R; Maniadakis N; Tavazzi L
    Value Health; 2015 Dec; 18(8):1098-104. PubMed ID: 26686796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
    Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
    Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland.
    Nicol ED; Fittall B; Roughton M; Cleland JG; Dargie H; Cowie MR
    Heart; 2008 Feb; 94(2):172-7. PubMed ID: 18003672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
    Watz R; Ekstrand AB; Engelbrektson V; Beermann B
    Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
    Komajda M; Lapuerta P; Hermans N; Gonzalez-Juanatey JR; van Veldhuisen DJ; Erdmann E; Tavazzi L; Poole-Wilson P; Le Pen C
    Eur Heart J; 2005 Aug; 26(16):1653-9. PubMed ID: 15827061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the management of heart failure in primary care.
    Calvert MJ; Shankar A; McManus RJ; Ryan R; Freemantle N
    Fam Pract; 2009 Apr; 26(2):145-53. PubMed ID: 19153098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Euro heart failure survey. Medical treatment not in line with current guidelines.
    Drechsler K; Dietz R; Klein H; Wollert KC; Storp D; Molling J; Zeymer U; Niebauer J
    Z Kardiol; 2005 Aug; 94(8):510-5. PubMed ID: 16049652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Knowledge of primary care physicians, cardiologists from cardiology clinics, internal and cardiology department physicians about chronic heart failure diagnosis and treatment].
    Wierzchowiecki M; Poprawski K; Nowicka A; Kandziora M; Piatkowska A
    Pol Merkur Lekarski; 2005 Feb; 18(104):210-5. PubMed ID: 17877133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy modifications during hospitalization in patients with chronic heart failure.
    Detiček A; Locatelli I; Roblek T; Mrhar A; Lainscak M
    Eur J Intern Med; 2016 Apr; 29():52-8. PubMed ID: 26775137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF.
    Voors AA; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Ter Maaten JM; Ng L; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; Metra M
    Eur J Heart Fail; 2016 Jun; 18(6):716-26. PubMed ID: 27126231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.